Loading...
Loading...
India's diphenhydramine imports from UNITED STATES total $9.6K across 27 shipments from 13 foreign suppliers. BIONPHARMA INC leads with $4.8K in import value; the top 5 suppliers together control 94.8% of this origin. Leading Indian buyers include NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for diphenhydramine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

BIONPHARMA INC is the leading Diphenhydramine supplier from UNITED STATES to India, with import value of $4.8K across 6 shipments. The top 5 suppliers — BIONPHARMA INC, REGIONAL PHARMACY, GOOD HELTH PHARMA SUPPLIES, USPHARMA LTD, Uspharma Ltd. — collectively account for 94.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIONPHARMA INC | $4.8K | 6 | 49.7% |
| 2 | REGIONAL PHARMACY | $2.7K | 3 | 27.9% |
| 3 | GOOD HELTH PHARMA SUPPLIES | $914 | 1 | 9.5% |
| 4 | USPHARMA LTD | $517 | 5 | 5.4% |
| 5 | Uspharma Ltd. | $227 | 1 | 2.4% |
| 6 | AMSTERDAM PHARMA (APTEKA RX INC) | $177 | 1 | 1.8% |
| 7 | GSK CONSUMER HEALTHCARE (HALEON) | $88 | 1 | 0.9% |
| 8 | TIME-CAP LABS, INC. | $70 | 2 | 0.7% |
| 9 | M/S. REGIONAL PHARMACY | $62 | 2 | 0.6% |
| 10 | USPHARMA LIMITED | $49 | 1 | 0.5% |
| 11 | M/S AUROHEALTH | $29 | 1 | 0.3% |
| 12 | GRANULES USA INC | $16 | 2 | 0.2% |
| 13 | M/S Aurohealth, LLC | $8 | 1 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED | $3.7K | 2 | 38.7% |
| 2 | MICRO LABS LIMITED | $2.7K | 3 | 27.9% |
| 3 | ORBION PHARMACEUTICALS PRIVATE LIMITED | $1.1K | 4 | 10.9% |
| 4 | HETERO LABS LIMITED | $914 | 1 | 9.5% |
| 5 | FIRST TIME US PHARMACEUTICALS (INDIA) PRIVATE LIMI | $693 | 5 | 7.2% |
| 6 | INVENTIA HEALTHCARE LIMITED | $177 | 1 | 1.8% |
| 7 | SARVOTHAM CARE LIMITED | $88 | 1 | 0.9% |
| 8 | MARKSANS PHARMA LIMITED | $70 | 2 | 0.7% |
| 9 | GLAND PHARMA LIMITED | $62 | 2 | 0.6% |
| 10 | FIRST TIME US PHARMACEUTICALS (INDIA) PVT. LTD. | $50 | 1 | 0.5% |
| 11 | FIRST TIME US PHARMACEUTICALS INDIA PRIVATE LIMITED | $49 | 1 | 0.5% |
| 12 | AUROBINDO PHARMA LTD | $37 | 2 | 0.4% |
| 13 | GRANULES INDIA LIMITED | $16 | 2 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Diphenhydramine suppliers from UNITED STATES to India include BIONPHARMA INC, REGIONAL PHARMACY, GOOD HELTH PHARMA SUPPLIES. The leading supplier is BIONPHARMA INC with import value of $4.8K USD across 6 shipments. India imported Diphenhydramine worth $9.6K USD from UNITED STATES in total across 27 shipments.
India imported Diphenhydramine worth $9.6K USD from UNITED STATES across 27 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Diphenhydramine sourced from UNITED STATES include NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED, MICRO LABS LIMITED, ORBION PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED with $3.7K in imports across 2 shipments.
The total value of Diphenhydramine imports from UNITED STATES to India is $9.6K USD, across 27 shipments and 13 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
27 Verified Shipments
13 suppliers, 13 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists